Single Cell Technology
Biotech firm, Single Cell Technology, develops tech for antibody analysis and offers contract services.
Founded
2008Biotech firm, Single Cell Technology, develops tech for antibody analysis and offers contract services.
Founded with a mission to revolutionize antibody discovery and analysis, Single Cell Technology Inc. leverages a cutting-edge platform to examine and screen plasma cells in lymphoid tissues. The company's technology focuses on measuring the affinity and specificity of antibodies from various hosts, including humans and mice. In addition to developing proprietary technologies, Single Cell Technology offers contract services to biotech firms and research institutions, aiming to accelerate advancements in immunology and therapeutic development.
Notable figures associated with Single Cell Technology include leading scientists and industry experts who have contributed to the company's innovative approaches. The company has secured investments from key players in the biotech sector, enabling it to expand its research capabilities and service offerings. Achievements include successful collaborations with top-tier research institutions and pharmaceutical companies, significantly impacting the field of antibody discovery and therapeutic development.
Companies similar to Single Cell Technology include AbCellera Biologics, Celldom, Partillion Bioscience and Scribe Biosciences.
Single Cell Technology was founded in 2008.
Single Cell Technology's headquarters is located in San Jose, CA, US.
Single Cell Technology's most recent funding round was for $323.8k (USD) in December 2012.
As of Dec 20, 2012, Single Cell Technology has disclosed funding of $323.8k (USD). Undisclosed round amounts are excluded.
Single Cell Technology has 13 employees as of Feb 5, 2024.
Scribe Biosciences
